文献速递妇科

组织学模式与瘤内异质性用于高级别浆液性卵巢癌预后判断

Histological patterns and intra-tumor heterogeneity as prognostication tools in high grade serous ovarian cancers.
PubMed 文献 · Gynecol Oncol · 2021-10-01

该研究对234例高级别浆液性卵巢癌患者的695张切片进行形态学与架构特征分析,包括SET特征、肿瘤浸润淋巴细胞、坏死、核分裂数、砂粒体、巨细胞及非典型核分裂,并用Shannon多样性指数量化瘤内异质性。结果显示,具有SET特征者总生存和无进展生存更长;在新辅助化疗患者中,瘤内异质性高是不良独立预后因素。

要点

  • SET特征(尤其假子宫内膜样和移行细胞样)与更长的总生存和无进展生存相关。
  • 实体模式预后因BRCA1状态和异质性而异,BRCA1阴性且异质性低者预后更好。
  • 新辅助化疗后瘤内异质性高(SDI高)是不良独立预后因素。

核心结论

  • 综合评估架构模式及其异质性有助于高级别浆液性卵巢癌的预后判断。

研究设计与样本

  • 回顾性队列研究,纳入234例高级别浆液性卵巢癌患者,分析695张切片。
  • 记录形态学与架构特征并用Shannon多样性指数量化瘤内异质性。

主要发现

  • 架构模式和形态学变量的频率随手术策略(初次减灭 vs 新辅助化疗后间隔手术)而变化。
  • 具有SET特征的高级别浆液性卵巢癌总生存和无进展生存更长。
  • SET特征中假子宫内膜样和移行细胞样模式预后最佳。
  • 实体模式预后异质,BRCA1阴性且异质性较低者预后更好。
  • 接受新辅助化疗者中,SDI定义的高瘤内异质性为不良独立预后因素。

临床怎么用

  • 病理报告中可纳入架构模式(SET/经典)及瘤内异质性评估以辅助预后分层。
  • 对新辅助化疗后的患者,关注高瘤内异质性提示不良预后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: High grade serous ovarian carcinoma (HGSOC) is the most common type of malignant ovarian neoplasm and the main cause of ovarian cancer related deaths worldwide. Although novel biomarkers such as homologous recombination deficiency testing have been implemented into the clinical decision-making algorithm since diagnosis, morphological classification and immunohistochemistry analysis are essential for diagnostic purpose. This study aims at identifying histologic and clinical features that can be predictive of patients' prognosis. METHODS: Morphological and architectural characterization including SET (Solid-Endometroid-Transitional)/Classic features was carried out in a cohort of 234 patients analyzing 695 slides. From each slide tumor infiltrating lymphocyte (TILs), the presence of necrosis, the number of mitoses, the presence of psammoma bodies, giant cells and atypical mitoses were recorded. Morphological heterogeneity was quantified by the Shannon's diversity index (SDI) considering the percentage of each architectural pattern per patient's slide. RESULTS: The frequency of architectural patterns and morphological variables varied with respect of the surgical strategy (primary debulking surgery vs interval surgery after neoadjuvant chemotherapy). HGSOCs exhibiting SET features had a longer overall as well as progression free survival. Among SET features, pseudo-endometrioid and transitional like patterns had the best outcome, while it was heterogenous for solid pattern, that had better outcome for BRCA 1 negative and less heterogeneous tumors. In patients submitted to neoadjuvant chemotherapy a higher intratumor heterogeneity as defined by SDI was a negative independent prognostic factor. CONCLUSIONS: A comprehensive histological examination considering architectural patterns and their heterogeneity can help in prognostication of HGSOCs.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Azzalini E, Barbazza R, Stanta G, et al. Histological patterns and intra-tumor heterogeneity as prognostication tools in high grade serous ovarian cancers. Gynecol Oncol. 2021. PMID: 34602289. doi:10.1016/j.ygyno.2021.09.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。